VWR Acquires Reliable Biopharmaceutical and BioArra

Acquisitions Strengthen VWR’s Commitment to its Customers

RADNOR, Pa. — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today the acquisition of two companies, Reliable Biopharmaceuticaland BioArra.

Reliable Biopharmaceutical, a manufacturer of high quality active pharmaceutical ingredients (APIs) and high purity ingredients (HPIs) such as cGMP excipients and advanced intermediates for the biopharmaceutical industry, enhances VWR’s growing custom chemical and biochemical manufacturing portfolio. Reliable Biopharmaceutical offers highly-flexible, scalable and solution oriented production ranging from small batch clinical manufacturing to full scale commercial production. Based in St. Louis, Missouri and founded in 1968, Reliable Biopharmaceutical is a key supplier for many pharmaceutical, biopharmaceutical, diagnostic and cosmetic companies.

BioArra, a leading producer of U.S. origin serum-ba

< | >